Inner Mongolia Grand Pharmaceutical Co (BJSE:836433) 3-Year EBITDA Growth Rate : -38.60% (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Inner Mongolia Grand Pharmaceutical Co 3-Year EBITDA Growth Rate?

Inner Mongolia Grand Pharmaceutical Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.01.

During the past 12 months, Inner Mongolia Grand Pharmaceutical Co's average EBITDA Per Share Growth Rate was -67.50% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -38.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -25.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 11 years, the highest 3-Year average EBITDA Per Share Growth Rate of Inner Mongolia Grand Pharmaceutical Co was 22.40% per year. The lowest was -38.60% per year. And the median was -5.00% per year.

Competitive Comparison of Inner Mongolia Grand Pharmaceutical Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Inner Mongolia Grand Pharmaceutical Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Inner Mongolia Grand Pharmaceutical Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Inner Mongolia Grand Pharmaceutical Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Inner Mongolia Grand Pharmaceutical Co's 3-Year EBITDA Growth Rate falls into.

Inner Mongolia Grand Pharmaceutical Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Inner Mongolia Grand Pharmaceutical Co (BJSE:836433) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Inner Mongolia Grand Pharmaceutical Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Inner Mongolia Grand Pharmaceutical Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Inner Mongolia Grand Pharmaceutical Co (BJSE:836433) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Inner Mongolia Grand Pharmaceutical Co Ltd (BJSE:836433) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

Wuwei Road, 2nd Floor, Administration Building, Ruyi Development Zone, Inner Mongolia Autonomous Region, Hohhot, CHN, 010010

Website

http://www.nmdt.com.cn

Inner Mongolia Grand Pharmaceutical Co Ltd is a pharmaceutical enterprise integrating the development of Mongolian medicine resources. It engages in the research and development, production and sales of special specialty medicines and general health products. The company's main business is the research and development and production of Chinese patent medicines (including ethnic medicines) and chemical preparations and sales.

Inner Mongolia Grand Pharmaceutical Co (BJSE:836433) Headlines

No Headlines